|
|
||||||||
Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
| |
ABSTRACT |
|---|
|
|
|---|
Elevations of arginine vasopressin (AVP) binding to renal vasopressin V2 receptors (V2R) enhance water and urea reabsorption in the collecting duct epithelium. This study was designed to quantify the levels of V2R mRNA and protein within the distinct regions of the Sprague-Dawley rat kidney (i.e., the cortex and outer and inner medulla) during 24 and 48 h of water restriction. A competitive reverse transcription-polymerase chain reaction (RT-PCR) assay was developed to quantify changes in the V2R mRNA, in which a deletion mutant RNA transcript was used to control for the efficiency of RT-PCR. Western blot analysis was utilized for the quantification of the V2R protein. The results showed that the steady-state levels of the V2R mRNA decreased in a time-dependent manner in the cortex and outer and inner medulla throughout 48 h of water restriction. Western blot analysis revealed that the V2R protein in the renal cortex decreased after the initial 24 h of water restriction and remained decreased at 48 h. In contrast, outer medullary V2R protein decreased significantly only after 48 h of water restriction, whereas no significant change in the inner medullary V2R protein was observed throughout the 48 h of water restriction. These results suggest that water restriction leads to a regional time-dependent downregulation of the V2R mRNA and protein within the rat kidney. The stability of the plasma membrane V2R protein within the inner medulla may allow for the optimization of urine concentration and minimize water loss during periods of water restriction.
competitive reverse transcription-polymerase chain reaction; Western blot analysis; receptor downregulation; messenger ribonucleic acid quantitation; plasma membrane protein
| |
INTRODUCTION |
|---|
|
|
|---|
THE ABILITY OF MAMMALIAN organisms to conserve water depends on the release of arginine vasopressin (AVP), and the actions of this peptide on the vasopressin V2 receptors (V2R) depend on the basolateral membranes of the collecting ducts. This is accomplished by V2R-stimulated insertion of aquaporin-2 (AQP-2) water channels (12, 21, 22, 28) into the apical membrane of the collecting duct epithelium. Paradoxically, it has been demonstrated in vitro that pharmacological amounts of AVP lead to the downregulation of the V2R through multiple mechanisms (3, 4, 7, 14, 18, 26). It has also been reported using semiquantitative RT-PCR that prolonged water restriction for up to 72 h decreases the levels of V2R mRNA in isolated collecting ducts (32). Additionally, Firsov et al. (9) demonstrated that stimulation of the V2R using a highly selective V2R agonist, 1-desamino-8-D-arginine vasopressin (DDAVP), resulted in a reduction in the V2R mRNA in isolated renal tubules, which included thick ascending limbs of Henle and collecting ducts. Yet the downregulation of the V2R, particularly within the renal medulla, would appear to be counterproductive during water restriction, and it remains unknown whether the reduction of the V2R mRNA is associated with a parallel reduction in the V2R protein.
The present study was, therefore, designed to determine whether specific regional differences of the V2R mRNA and/or protein levels occur between the renal cortex and medulla during 24 and 48 h of water restriction. A highly sensitive competitive RT-PCR assay was developed to quantitate the changes in the steady-state level of the V2R mRNA, and a polyclonal antibody specific to the V2R protein was generated to determine alterations in the V2R protein by Western blot analysis.
| |
METHODS |
|---|
|
|
|---|
Experimental animals. Male Sprague-Dawley rats (360-420 g) from Harlan (Madison, WI) were used in the protein and RNA isolation. All animals were fed a standard pellet diet (Purina Mills, St. Louis, MO) and ad libitum water to drink until the beginning of the water restriction protocol. All protocols were approved by the Institutional Animal Care and Use Committee of the Medical College of Wisconsin.
Tissue isolation. Kidneys from control ad libitum water, 24 h, and 48 h water-restricted rats were collected, and the RNA and protein were isolated. The left kidney was used for the RNA extraction, and the right kidney was used for protein isolation. The kidneys were coronally cut, which allowed for the visualization and removal of the three distinct regions of the kidney: the cortex and outer and inner medulla.
RNA isolation. RNA was isolated from
the renal cortex and outer and inner medulla using TRIzol reagent
(GIBCO-BRL; Life Technologies, Gaithersburg, MD). The extracted RNA was
resuspended in diethyl pyrocarbonate (DEPC)-treated water (50 µl for
the outer and inner medulla and 100 µl for the cortex). The RNA was
quantified using a Beckman ultraviolet spectrophotometer at 260 nm, and
the resuspended RNA was then frozen at
80°C.
Preparation of oligonucleotide primers. All nucleotide primers were purchased from Operon Technologies (Alameda, CA). Oligonucleotide primers were chosen from the published full-length cDNA sequences of rat V2R (19). The oligonucleotides used for amplification correspond to the following sequences: primer A, 5' ATG GTG GGC ATG TAT GCC TCC TCC TAC ATG 3' (position 399-427 bp); primer B, 5' AGT GTC ATC CTC ACG GTC TTG GCC A 3' (position 835-859 bp); and primer C, 5' GAC ATA GGC ACG AAG GCC CCA 3' (position 638-659 bp).
Construction of mutant V2R. The initial V2R PCR product was amplified with primers A and B and cloned into the pCRII vector (Invitrogen, Carlsbad, CA). The DNA insert was excised from the vector by EcoR I digestion and gel purified (Qiagen, Chatsworth, CA). The purified EcoR I fragment was digested with Dde I to delete a 29-bp fragment (bp 548-578), and the digestion products (149 and 282 bp) were isolated and gel purified. The DNA fragments were ligated for 1 h at 16°C with T4 DNA ligase (Pharmacia, Piscataway, NJ). The ligation product was amplified with primers A and B, and the PCR products with the expected size were cloned into the pCR2.1 vector (Invitrogen) and then subcloned into the pSP64 poly(A) vector (Promega, Madison, WI). Transformants with the correct size were isolated and sequenced to ensure the removal of the 29 bp in the vasopressin V2 receptor deletion mutant.
In vitro transcription of mutant
V2R RNA. One
microgram of BamH I-digested plasmid was transcribed
with 10 U SP6 RNA polymerase (Promega). The transcription solution
consisted of (in mM) 40 Tris · HCl, pH 7.9, 6 MgCl2, 10 dithiothreitol, 2 spermidine, 0.5 rNTP mix, and 40 U
RNAsin. The transcription reaction was incubated at 37°C for 60 min, and then 5 U RQ1 RNase-free DNase was added to digest the plasmid
for 30 min at 37°C. The transcribed RNA was then re-extracted with
100 µl TRIzol reagent, as described earlier. The RNA pellet was
resuspended with DEPC-treated water, and the RNA concentration was
determined by ultraviolet spectrophotometry. The deletion mutant
transcript was aliquoted and frozen at
80°C.
Competitive RT-PCR. Initial experiments were performed to determine the amounts of total RNA needed from each of the kidney regions to allow for the RT-PCR amplification to occur within the same range of deletion mutant transcript. The amount of total RNA necessary for RT was 1 ng for the inner medulla, 3 ng for the outer medulla, and 5-10 ng for the cortex in combination with different amounts of mutant V2R transcript (ranging from 4 to 280 zmol), using 10 pmol of primer C. All RNA samples (i.e., the control group and the corresponding experimental groups) from each kidney region were run simultaneously in each assay to minimize potential interassay variability. The RNA was incubated at 65°C for 10 min and then immediately placed on ice. The RT-PCR was performed as previously described (25). All PCR reactions were performed in the same tube as the RT reaction and were adjusted to a final volume of 50 µl. The PCR reaction conditions were optimal using 1.0 mM MgCl2, 50 pmol of each primer (A and C), and 2.5 U AmpliTaq polymerase (Perkin-Elmer Cetus, Norwalk, CT). The reaction mixture was first denatured at 96°C for 5 min and then at 80°C while AmpliTaq polymerase (2.5 U) was added to each of the reaction tubes. The reactions were cycled for 32 cycles at 94, 66, and 72°C for 1 min at each step. Samples were then incubated for an additional 7 min at 72°C for final extension. Negative controls used in this experiments were PCR amplification of sterile water, mutant V2R RNA transcript, and tissue RNA without RT.
Competitive RT-PCR product analysis. Ten-microliter aliquots of the PCR products were electrophoresed on a 2% agarose gel (75% regular agarose, 25% low-melting agarose). After electrophoresis and ethidium bromide staining, the gel was scanned with a FluorImager (Molecular Dynamics, Sunnyvale, CA). The bands were quantitated using ImageQuant software and then subsequently plotted to determine the equivalence point (i.e., the point at which the number of known mutant V2R transcripts is equal to the number of unknown V2R mRNA molecules in a given amount of total RNA). Competitive RT-PCR assays were run in triplicate for each RNA sample to obtain an average calculated value for the equivalence point.
Plasma membrane-enriched fraction protein isolation. The kidneys from control ad libitum water-restricted and 24 and 48 h water-restricted rats were coronally sectioned, and the three renal regions (renal cortex and outer and inner medulla) were isolated. The renal tissue was homogenized in (in mM) 5 K2HPO4, 5 KH2PO4, 250 sucrose, pH 7.7, 0.1 EDTA, 0.1 phenylmethylsulfonyl fluoride, 2 µg/µl leupeptin, and 5 µg/µl pepstatin. The centrifugation protocol was a slight modification of Ecelbarger et al. (8), in which the homogenate was initially centrifuged at 1,000 g to remove any incompletely homogenized membrane fragments and nuclei. The supernatant was then centrifuged at 16,000 g for 20 min. The pellet, which contains predominantly plasma membrane protein, was then resuspended in homogenization buffer. The protein concentrations were determined at 595 nm using the Coomassie method (Pierce, Rockford, Il).
Western blot analysis. Sample buffer
[2% SDS, 100 mM Tris · HCl, pH 6.8, 5%
-mercaptoethanol, 12% (vol/vol) glycerol, and 0.02% (wt/vol)
bromophenol blue] was added to the protein sample and then
incubated at 100°C for 5 min. Aliquots of 4 µg of inner medullary, 16 µg of outer medullary, and 16 µg of cortical membrane protein were loaded onto each lane and size separated by
electrophoresis through a 12% SDS-PAGE gel. The proteins were
transferred onto a nitrocellulose membrane (Bio-Rad, Hercules, CA),
which was then blocked overnight at 4°C with 12% nonfat dried milk
in blotting solution. The following day, the membranes were incubated
for 1 h with the primary antibody (1:1,500) at room temperature. To determine the specificity of the
V2R antibody, membranes were incubated with the V2R antibody
preadsorbed with the competing immunogenic peptide and the preimmune
serum. The membranes were subsequently incubated for 1 h with secondary
antibody (goat anti-rabbit IgG; 1:1,500, Bio-Rad) at room temperature.
The membranes were placed in a chemiluminescent solution (WesternView;
Transduction Laboratories, Lexington, KY) to enable visualization of
the protein bands on film. The bands were quantitated by densitometry
(Molecular Dynamics). Each of the membranes was stripped and reprobed
with
-actin (1:2,500) to ensure equal loading of proteins in each lane.
Statistical analysis. The significance
of differences between groups was tested by one-way ANOVA with the use
of SigmaStat software. If a probability value of
P
0.05 was obtained, the Tukey test
was then used for comparison of each individual group with the
appropriate control.
| |
RESULTS |
|---|
|
|
|---|
Construction of deletion mutant V2R transcript. The use of an exogenous internal RNA standard enabled precise quantitation of tissue V2R mRNA in the present study. A deletion mutant RNA transcript was made in these studies that contained the same nucleotide sequence as the wild-type mRNA, except for a small nucleotide deletion of 29 bp. As shown in Fig. 1, the initial RT-PCR product of 461 bp was produced using primers A and B, and subsequent endonuclease digestion with Dde I removed the 29 bp (Fig. 1, hatched box) from the wild-type V2R sequence. The deletion mutant for the V2R was clearly distinguishable from the wild-type (tissue) V2R by restriction enzyme digestion, and final validation on the removal of the 29-bp Dde I fragment was achieved by PCR sequencing (data not shown).
|
Validation of the efficiency and reproducibility of
competitive RT-PCR assay. As shown in Fig.
2, it was first established that the
amplification of the deletion mutant RNA transcript and the tissue
(wild type) RNA were similar, a prerequisite for accurate quantitation.
Figure 2A is a representative
experiment (from 5 independent experiments) of an ethidium
bromide-stained gel, in which 1 ng of inner medullary total RNA
(lanes 2-6) and 160 zmol of
deletion mutant transcript (lanes
7-11) were RT-PCR amplified for 30-35
cycles in one-cycle increments. Figure
2B is a graphical representation of
the band intensity of Fig. 2A, which
demonstrates that the slope of the line for tissue
V2R mRNA (
) was parallel to the
V2R mutant (
). These
experiments showed that the efficiencies of RT-PCR amplification for
the mutant and the tissue products were equivalent, a critical
requirement for the quantification of mRNA using RT-PCR.
|
To determine both the range of total RNA that could be measured by the assay and the accuracy of the competitive RT-PCR assay, three different amounts of inner medullary total RNA (1, 5, and 25 ng) were used (Fig. 3). To determine the equivalence point (i.e., the point at which the number of mutant V2R transcripts equals the number of tissue mRNA), seven different amounts of mutant RNA transcript were added to a constant amount of tissue total RNA (either 1, 5, or 25 ng). Figure 3A demonstrates an ethidium bromide-stained gel of a competitive RT-PCR assay, using 1 ng of inner medullary total RNA with competing amounts of mutant V2R RNA ranging from 4 to 400 zmol (lanes 2-8). Negative control reactions were performed in each assay, which included the PCR amplification of tissue RNA (lane 9) and mutant RNA (lane 10) without RT and PCR amplification of sterile water (lane 11). Figure 3B demonstrates the densitometric analysis of the gel shown in Fig. 3A, the results of which were used to determine the amount of tissue mRNA at the equivalence point. The majority of the graphical analyses for the quantitative RT-PCR assay had r > 0.9, and any analysis where r < 0.8 was discarded.
|
Five independent experiments were conducted using 1, 5, and 25 ng of inner medullary total RNA, and the equivalence points were determined as shown in Fig. 3C. The calculated tissue RNA contents of the V2R were 486 ± 46.0 zmol, using 25 ng of total RNA; 112 ± 13.3 zmol, using 5 ng of total RNA; and 24.0 ± 3.9 zmol, using 1 ng of total RNA. This shows that, for from 25 to 5 ng of total RNA, there was a 4.4-fold difference and that, for from 5 to 1 ng, there was a 4.7-fold difference. The competitive RT-PCR developed for the V2R is therefore quite proportional throughout the range from 1 to 25 ng of total RNA from the inner medulla and enables small changes in V2R mRNA to be determined in minute nanogram amounts of tissue RNA.
Competitive RT-PCR analysis for the cortex and outer and inner medulla. As illustrated in Fig. 4, the steady-state levels of cortical V2R mRNA averaged 8.37 ± 1.06 zmol/ng total RNA (means ± SE) in control rats (n = 3) with ad libitum water. After 24 h of water restriction, the steady-state levels decreased significantly to 3.49 ± 0.39 zmol/ng total RNA (P < 0.05), which remained decreased, averaging 4.12 ± 0.23 zmol/ng total RNA (P < 0.05) after 48 h of water restriction. In the outer medulla, the V2R mRNA levels averaged 44.5 ± 7.57 zmol/ng total RNA, which decreased to 27.9 ± 3.51 zmol/ng total RNA after 24 h of water restriction. After 48 h of water restriction, the V2R mRNA of the outer medulla decreased further to an average of 15.5 ± 3.54 zmol/ng total RNA (P < 0.05). In the inner medulla, the V2R mRNA levels averaged 95.8 ± 4.75 zmol/ng total RNA during control ad libitum water conditions, a value significantly higher than that found in the cortex and outer medulla under the same conditions (P < 0.001). During the 24-h water restriction period, the steady-state levels of the V2R mRNA decreased to 60.3 ± 15.2 zmol/ng total RNA and continued to fall significantly to 28.7 ± 3.19 zmol/ng total RNA (P < 0.05) after 48 h of water restriction.
|
Specificity of the V2R antibody. We have previously demonstrated the binding specificity of the V2R antibody, which was produced in our laboratory (25). In the present study, we used inner medullary plasma membrane-enriched protein (16,000 g pellet) to illustrate the specificity of the V2R antibody. Figure 5 demonstrates that neither the primary V2R antibody preadsorbed with the competing antigenic peptide (preadsorption) nor the preimmune serum produced an immunogenic signal for the V2R protein. The predominant band was found at ~40 kDa, which is the expected size of the V2R. There was also an occasional band seen at ~80 kDa, which is presumably a receptor dimer of the V2R, which has been previously observed for the human V2R by Sadeghi et al. (27).
|
Western blot analysis of the V2R protein. Western blot analyses were performed on the plasma membrane-enriched fractions (16,000 g pellet) from the cortex (Fig. 6) and outer (Fig. 7) and inner medulla (Fig. 8). Figure 6A illustrates the changes of the V2R in the plasma membrane-enriched fraction from the cortex of rats after 24 (top, n = 6) and 48 (bottom, n = 6) h of water restriction compared with control rats with ad libitum water (control, n = 6). Figure 6B summarizes the densitometric measurements of the 40.5-kDa band, which is the expected size of the V2R. The V2R decreased significantly after 24 h of water restriction (means ± SE, 54.3 ± 7.0% of control) and remained decreased through 48 h of water restriction (58.0 ± 12.7%).
|
|
|
Interestingly, within the renal medulla, the results of our analysis suggest a differential regulation of the V2R within the plasma membrane. In the outer medulla, the plasma membrane-enriched fraction, as shown in Fig. 7A and densitometrically analyzed in Fig. 7B, shows that there is no change from control after 24 h of water restriction (n = 6, 5.0 ± 2.9% of control), but, after 48 h of water restriction, there is a significant decrease of 62 ± 5.2%. Within the inner medulla (Fig. 8), there was no significant alteration of the V2R protein at either 24 or 48 h of water restriction, in contrast to that observed in the cortex and outer medulla.
There was no difference in
-actin in the control ad libitum water
compared with the 24- or 48-h water restriction rats (data not shown),
confirming that there was equal loading of the protein samples in the
gel.
| |
DISCUSSION |
|---|
|
|
|---|
Detection of tissue mRNA has traditionally been performed with Northern
blot analyses or RNase protection assays. However, one major drawback
of these techniques is their lack of sensitivity, and so this
necessitates the pooling of tissue samples. To circumvent this problem,
quantitation of mRNA by RT-PCR has recently been developed (11, 29).
The majority of mRNA measurements by RT-PCR have been made using
semiquantitative methods, in which the mRNA of interest is compared
with an internal housekeeping gene, such as glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) or
-actin. However, because of the intrinsic
variability of the RT-PCR assay, particularly between different mRNAs,
precise quantification of the tissue mRNA requires the utilization of a
known exogenous RNA transcript. The development of an exogenous RNA
transcript for use as an internal standard enables one to fully control
the potential sources of variability that can arise in the measurement of mRNA, particularly during the RT reaction (11, 29). This provides a
powerful RT-PCR-based approach for quantifying tissue mRNA levels with
exquisite sensitivity for the determination of mRNA levels within
small, unpooled tissue samples. The mutant RNA transcript, which we
developed, possessed the same nucleotide sequence as the wild-type
mRNA, minus the small nucleotide deletion (29 bp in our case).
Importantly, this mutant RNA transcript exhibited nearly identical
amplification efficiency as the tissue mRNA (Fig. 2), which enabled
this transcript to be used as a valid internal standard to quantify
unknown amounts of wild-type V2R
mRNA and to monitor and control for variations in efficiencies of both the RT and PCR reactions.
Vasopressin receptor-mediated response to water restriction. The hydraulic conductivity of the medullary collecting duct epithelial cells has long been known to be dependent on V2R stimulation by AVP. Recent studies in our laboratory have also found that optimization of urine concentration is dependent on AVP-mediated reductions in medullary vasa recta blood flow, which minimizes the "washout" of the interstitial solute gradient required for water reabsorption. Specifically, 48 h of water restriction resulted in an elevation in plasma AVP levels from 3 to 20.5 pg/ml and an associated 30% reduction in vasa recta blood flow to the inner medulla as measured by laser-Doppler flowmetry in unanesthetized Sprague-Dawley rats (10).
The V2R has been largely localized
to extravascular structures, in particular, the medullary thick
ascending limbs of Henle and the collecting ducts (9, 24, 25, 32). The
enhanced hydraulic conductivity and urea reabsorption stimulated by AVP results from V2R-mediated
insertion of AQP-2 water channels and activation of urea UT1
transporters in the apical membranes of the collecting duct epithelium.
Furthermore, stimulation of the V2R in the medullary thick
ascending limbs of Henle activates the
Na+-K+-2
Cl
cotransporter (2, 30),
which increases NaCl reabsorption. This increased activity enhances the
generation of the medullary sodium osmotic gradient and, together with
urea, determines the corticopapillary interstitial solute gradient
necessary for urine concentration.
Evidence for AVP-mediated V2R regulation. Although there is a wealth of functional information related to the various actions of AVP on distinct tubular and vascular structures in the kidney, the physiological mechanisms that regulate the expression of the vasopressin receptors, in particular, the V2R, are not clearly understood. The goal of the present study was to characterize the regulation of these receptors at the level of mRNA and protein within the cortex and outer and inner medulla of the rat kidney during the first 2 days of water restriction. In vitro studies suggest that elevation in AVP would result in the downregulation of the V2R (3, 4, 7, 14, 18, 26). These studies demonstrate, however, that receptor downregulation is a multifactorial phenomenon that can involve receptor occupancy, receptor-mediated endocytosis, decrease in the receptor mRNA and/or protein levels, phosphorylation of the receptor, alterations in the affinity of the receptor to the agonist, or an uncoupling of the hormone receptor to its second messenger system. Several in vitro experiments have shown that cells transfected with the V2R mRNA could be desensitized when exposed to high concentrations of AVP (3, 14). Scatchard plot analysis indicated that AVP altered the V2R from a high-affinity receptor to a lower-affinity receptor (3). Conflicting results at this time make it unclear whether the desensitization is related to receptor phosphorylation (14, 26).
Recent studies (9, 32) have attempted to understand the in vivo effects on V2R of chronic stimulation, using RT-PCR on RNA obtained from microdissected thick ascending limbs of Henle and collecting ducts. Terada et al. (32) reported a decrease of V2R mRNA in medullary collecting ducts during 72 h of water restriction. However, the changes in the mRNA were calculated using a semiquantitative method, in which the V2R band intensity was compared with that of GAPDH. Firsov et al. (9), however, developed a quantitative RT-PCR assay and found that intramuscular injections of a highly selective V2R agonist, DDAVP, administered daily for 3 days, led to a decrease in the steady-state levels of the V2R mRNA in isolated renal tubules, which included the medullary thick ascending limbs and collecting ducts. This suggested that chronic stimulation of the V2R was responsible for the decrease in the V2R mRNA by influencing either the transcription of the gene or the stability of the mRNA. The signaling pathways for such changes remains to be established.
Regional time-dependent downregulation of the V2R mRNA and protein. The results of the present study demonstrate a global decrease in the renal V2R mRNA during 48 h of water restriction. Because of the functional importance of the V2R during water restriction, it was important in our study to determine whether the V2R protein decreased concomitantly. This indeed was the case, but the reduction in protein levels appeared to decrease after the changes in the V2R mRNA, and interestingly, in the inner medulla, the proteins were not significantly altered, even after 2 days of water restriction. Regional changes in V2R protein expression with water restriction have not previously been studied. Steiner and Phillips (31) studied tissue from whole rat kidney and showed that water restriction for 72 h led to a 38% decrease in the Bmax of AVP but did not affect the receptor affinity to AVP as found under in vitro conditions (3, 14).
We can only speculate about the mechanisms responsible for the regional time-dependent differences between V2R mRNA and protein expression found in our study. The steady-state levels of the mRNA were ~12-fold higher in the inner medulla, compared with the cortex in the euvolemic rats. The observed decrease of cortical V2R protein levels observed after 24 h of water restriction was correlated with a significant decrease in the steady-state levels of the V2R mRNA. However, at 48 h, reduced V2R mRNA in the renal inner medulla occurred in the absence of reduced V2R protein. This could be explained by the observation that even though the V2R mRNA was reduced, the levels still remained higher than those observed in the euvolemic state in the renal cortex, so protein translation may have continued throughout the 48 h period of water restriction. Alternatively, it is possible that elevations of extracellular osmolality within the renal medulla could enhance the stability of the protein within the epithelial membranes. Several investigators have found that hypertonicity leads to an enhancement in the adenylyl cyclase activity of vasopressin-sensitive cells (1, 16, 20), and it has been observed that hyperosmolality can inhibit the movement of clathrin into the coated pits within the plasma membrane (5, 13) and thereby decrease the occurrence of receptor-mediated endocytosis. These or other yet unknown mechanisms could explain why the V2R within the plasma membrane of the inner medulla was not altered during the 48 h of water restriction.
Physiological significance for differential V2R downregulation. The differential downregulation of the V2R within the distinct regions of the kidney (i.e., cortex and outer and inner medulla) could contribute importantly to the optimization of urine concentration and water conservation. The delayed reduction of the V2R in the inner medulla would prolong the conservation of free water during intermittent periods of water restriction. Studies by Lankford et al. (17) indicate that the water permeability of isolated perfused inner medullary collecting ducts is actually enhanced in 24 h water-restricted rats independent of AVP. In contrast, urea transport remained AVP dependent, which was attributed to a distinct post-second messenger pathway (6, 15, 23). Together with the present data, this would suggest that the maintenance of the V2R within the plasma membrane of the inner medulla provides optimization of urea transport through the collecting duct epithelium to enhance the osmotic drive for water reabsorption during water restriction.
In conclusion, this study has found that water restriction leads to a differential, time-dependent downregulation of the V2R mRNA and protein in the rat kidney. The stability of the plasma membrane V2R protein within the inner medulla may allow the mammalian organism to optimize urine concentration and ultimately minimize water loss during prolonged water restriction.
| |
ACKNOWLEDGEMENTS |
|---|
We would like to thank Meredith M. Skelton and David L. Mattson for their critical reading of this manuscript.
| |
FOOTNOTES |
|---|
Frank Park was supported by Wisconsin Affiliate, American Heart Association, Predoctoral Fellowship (96-F-PRE-15). This study was supported by the National Heart, Lung, and Blood Institute Grant HL-49219.
Address for reprint requests: F. Park, Dept. of Physiology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226.
Received 13 November 1997; accepted in final form 22 January 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Baudouin-Legros, M.,
A. Badou,
M. Paulais,
M. Hammet,
and
J. Teulon.
Hypertonic NaCl enhances adenosine release and hormonal cAMP production in mouse thick ascending limb.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F103-F109,
1995.
2.
Besseghir, K.,
M. E. Trimble,
and
L. Stoner.
Action of ADH on isolated medullary thick ascending limb of the Brattleboro rat.
Am. J. Physiol.
251 (Renal Fluid Electrolyte Physiol. 20):
F271-F277,
1986.
3.
Birnbaumer, M.,
A. Antaramian,
A. P. N. Themmen,
and
S. Gilbert.
Densitization of the human V2 vasopressin receptor.
J. Biol. Chem.
267:
11783-11788,
1992
4.
Carmelo, C.,
P. Tsai,
K. Okada,
V. A. Briner,
and
R. W. Schrier.
Mechanisms of rapid desensitization to arginine vasopressin in vascular smooth muscle cells.
Am. J. Physiol.
260 (Renal Fluid Electrolyte Physiol. 29):
F46-F52,
1991
5.
Carpentier, J.-L.,
F. Sawano,
D. Geiger,
P. Gorden,
A. Perrelt,
and
L. Orci.
Potassium depletion and hypertonic medium reduce "non-coated" and clathrin-coated pit formation, as well as endocytosis through the two gates.
J. Cell. Physiol.
138:
519-526,
1989[Medline].
6.
Chou, C.-L.,
J. M. Sands,
H. Nonoguchi,
and
M. A. Knepper.
Urea gradient-associated fluid absorption with
urea = 1 in rat terminal collecting duct.
Am. J. Physiol.
258 (Renal Fluid Electrolyte Physiol. 27):
F1173-F1180,
1990
7.
Dublineau, I.,
J.-M. Elalouf,
P. Pradelles,
and
C. de Rouffignac.
Independent desensitization of rat renal thick ascending limbs and collecting ducts to ADH.
Am. J. Physiol.
260 (Renal Fluid Electrolyte Physiol. 29):
F656-F663,
1991.
8.
Ecelbarger, C. A.,
J. Terris,
G. Frindt,
M. Echevarria,
D. Marples,
S. Nielson,
and
M. A. Knepper.
Aquaporin-3 water channel localization and regulation in rat kidney.
Am. J. Physiol.
269 (Renal Fluid Electrolyte Physiol. 38):
F663-F672,
1995
9.
Firsov, D.,
B. Mandon,
A. Morel,
J. Merot,
S. Le Maout,
A.-C. Bellanger,
C. de Rouffignac,
J.-M. Elalouf,
and
J.-M. Buhler.
Molecular analysis of vasopressin receptors in the rat nephron. Evidence for alternative splicing of the V2 receptor.
Pflügers Arch.
429:
79-89,
1994[Medline].
10.
Franchini, K. G.,
and
A. W. Cowley, Jr.
Renal cortical and medullary blood flow responses during water restriction: role of vasopressin.
Am. J. Physiol.
270 (Regulatory Integrative Comp. Physiol. 39):
R1257-R1264,
1996
11.
Gilliland, G.,
S. Perrin,
K. Blanchard,
and
B. Franklin.
Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction.
Proc. Natl. Acad. Sci. USA
87:
2725-2729,
1990
12.
Hayashi, M.,
S. Sasaki,
H. Tsuganezawa,
T. Monkawa,
W. Kitajima,
K. Konishi,
K. Fushimi,
F. Marumo,
and
T. Saruta.
Expression and distribution of aquaporin of collecting duct are regulated by vasopressin V2 receptor in rat kidney.
J. Clin. Invest.
94:
1778-1783,
1994.
13.
Heuser, J. E.,
and
R. G. Anderson.
Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation.
J. Cell Biol.
108:
389-400,
1989
14.
Innamorati, G.,
H. Sadeghi,
A. N. Eberle,
and
M. Birnbaumer.
Phosphorylation of the V2 vasopressin receptor.
J. Biol. Chem.
267:
11783-11788,
1992.
15.
Knepper, M. A.,
and
S. Nielsen.
Kinetic model of water and urea permeability regulation by vasopressin in collecting duct.
Am. J. Physiol.
265 (Renal Fluid Electrolyte Physiol. 34):
F214-F224,
1993
16.
Kumar, R.
Endocytosis of the vasopressin receptor.
Semin. Nephrol.
14:
357-367,
1994[Medline].
17.
Lankford, S. P.,
C.-L. Chou,
Y. Terada,
S. M. Wall,
J. B. Wade,
and
M. A. Knepper.
Regulation of collecting duct water permeability independent of cAMP-mediated AVP response.
Am. J. Physiol.
261 (Renal Fluid Electrolyte Physiol. 30):
F554-F566,
1991
18.
Lester, B. R.,
J. R. Sheppard,
and
M. Burman.
Desensitization of LLC-PK1 cells by vasopressin results in receptor downregulation.
Mol. Cell. Endocrinol.
40:
193-204,
1985[Medline].
19.
Lolait, S. J.,
A. M. O'Carroll,
O. W. McBride,
M. Konig,
A. Morel,
and
M. J. Brownstein.
Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus.
Nature
357:
336-339,
1992[Medline].
20.
Lutz, W.,
and
R. Kumar.
Hypertonic sucrose treatment enhances second messenger accumulation in vasopressin-sensitive cells.
Am. J. Physiol.
264 (Renal Fluid Electrolyte Physiol. 33):
F228-F233,
1993
21.
Marples, D.,
M. A. Knepper,
E. I. Christensen,
and
S. Nielsen.
Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct.
Am. J. Physiol.
269 (Cell Physiol. 38):
C655-C664,
1995
22.
Nielsen, S.,
J. Muller,
and
M. A. Knepper.
Vasopressin- and cAMP-induced changes in ultrastructure of isolated perfused inner medullary collecting ducts.
Am. J. Physiol.
265 (Renal Fluid Electrolyte Physiol. 34):
F225-F238,
1993
23.
Nielsen, S.,
and
M. A. Knepper.
Vasopressin activates collecting duct urea transporters and water channels by distinct physical processes.
Am. J. Physiol.
265 (Renal Fluid Electrolyte Physiol. 34):
F204-F213,
1993
24.
Nonoguchi, H.,
A. Owada,
N. Kobayashi,
M. Takayama,
Y. Terada,
J. Koike,
U. Kazutomo,
F. Marumo,
T. Sakai,
and
K. Tomita.
Immunohistochemical localization of V2 receptor along the nephron and functional role of luminal V2 receptor in terminal inner medullary collecting ducts.
J. Clin. Invest.
96:
1768-1778,
1995.
25.
Park, F.,
D. L. Mattson,
M. M. Skelton,
and
A. W. Cowley, Jr.
Localization of the vasopressin V1a and V2 receptors in the rat renal cortical and medullary circulation.
Am. J. Physiol.
273 (Regulatory Integrative Comp. Physiol. 42):
R243-R251,
1997
26.
Roy, C.,
and
D. A. Ausiello.
Regulation of vasopressin binding to intact cells.
Ann. NY Acad. Sci.
372:
92-105,
1981[Medline].
27.
Sadeghi, H. M.,
G. Innamorati,
M. Dagarag,
and
M. Birnbaumer.
Palmitoylation of the V2 vasopressin receptor.
Mol. Pharmacol.
52:
21-29,
1997
28.
Saito, T.,
S. Ishikawa,
S. Sasaki,
N. Fujita,
K. Fushimi,
K. Okada,
K. Takeuchi,
A. Sakamoto,
S. Ookawara,
T. Kaneko,
F. Marumo,
and
T. Saito.
Alteration in water channel AQP-2 by removal of AVP stimulation in collecting duct cells of dehydrated rats.
Am. J. Physiol.
272 (Renal Physiol. 41):
F183-F191,
1997
29.
Santagati, S.,
E. Bettini,
M. Asdente,
M. Muramatsu,
and
A. Maggi.
Theoretical considerations for the application of competitive polymerase chain reaction to the quantitation of a low abundance mRNA estrogen receptor.
Biochem. Pharmacol.
46:
264-272,
1993.
30.
Schlatter, E.,
and
R. Greger.
cAMP increases the basolateral Cl
conductance in the isolated perfused medullary thick ascending limb of Henle's look of the mouse.
Pflügers Arch.
405:
367-376,
1985[Medline].
31.
Steiner, M.,
and
M. I. Phillips.
Renal tubular vasopressin receptors downregulated by dehydration.
Am. J. Physiol.
254 (Cell Physiol. 23):
C404-C410,
1988
32.
Terada, Y.,
K. Tomita,
H. Nonoguchi,
T. Yang,
and
F. Marumo.
Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction.
J. Clin. Invest.
92:
2339-2345,
1993.
This article has been cited by other articles:
![]() |
A. M. Jensen, E. H. Bae, R. A. Fenton, R. Norregaard, S. Nielsen, S. W. Kim, and J. Frokiaer Angiotensin II regulates V2 receptor and pAQP2 during ureteral obstruction Am J Physiol Renal Physiol, January 1, 2009; 296(1): F127 - F134. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Izumi, Y. Nakayama, H. Memetimin, T. Inoue, Y. Kohda, H. Nonoguchi, and K. Tomita Regulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1170 - F1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Fenton, L. Brond, S. Nielsen, and J. Praetorius Cellular and subcellular distribution of the type-2 vasopressin receptor in the kidney Am J Physiol Renal Physiol, September 1, 2007; 293(3): F748 - F760. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Machida, S. Wakamatsu, Y. Izumi, T. Yosifovska, T. Matsuzaki, Y. Nakayama, Y. Kohda, T. Inoue, H. Saito, K. Tomita, et al. Downregulation of the V2 vasopressin receptor in dehydration: mechanisms and role of renal prostaglandin synthesis Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1274 - F1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. B. Vagnes, F. H. Hansen, R. E. F. Christiansen, C. Gjerstad, and B. M. Iversen Age-dependent regulation of vasopressin V1a receptors in preglomerular vessels from the spontaneously hypertensive rat Am J Physiol Renal Physiol, May 1, 2004; 286(5): F997 - F1003. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |